Mckesson Corporation

NYSE: MCK
$539.94
+$4.52 (+0.8%)
Closing price April 25, 2024
Mckesson Corporation is a global healthcare services provider, offering a wide range of products and services. Its operations span across pharmaceutical distribution, including branded, generic, and specialty drugs, as well as over-the-counter products. The company also delivers technology solutions for pharmacies, practice management, and clinical support to specialty practices. Additionally, Mckesson plays a crucial role in connecting various healthcare stakeholders, such as patients, pharmacies, and biopharma companies, through its Prescription Technology Solutions. It further supports healthcare providers with medical-surgical supplies and logistics. Founded in 1833, Mckesson is headquartered in Irving, Texas, serving customers in the U.S. and internationally.
In the wake of changes to the UBS Equity Focus list, 24/7 Wall St. scanned the list for the top yielding tech stocks.
A new research note from Cowen focuses on health care companies that have released earnings and offer investors reasons to own the stocks.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Wednesday, October 8, 2014.
The UBS team highlights six top stocks that are seeing increased prescription volume since the implementation of parts of the Affordable Care Act.
Source: ThinkstockThe United States is not alone as our population ages. We join Japan and several other developed nations with a larger percentage of the population growing older. Better diet,...
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, March 12, 2014. They include AIG, General Motors, Rite Aid, Synta Pharmaceuticals and...
Shares of drugstore operator Rite Aid dropped about 3% in morning trading Monday. This after the stock it a new multiyear high on Friday following last week's news that it had signed a major...
Source: Frank Golhen, via Wikimedia CommonsMost of the firms that we cover on Wall Street have presented their high conviction stock picks for 2014. The analysts at Credit Suisse have taken a little...
Source: ThinkstockTraditionally, the term “January Effect” was used to explain a seasonal anomaly where the stock market had a tendency to rally during the month of January. However, the analysts...
Source: ThinkstockAs we head in to the final month of what has been a tremendous year for the stock market, the 24/7 staff is reviewing what the major Wall Street firms are recommending for the...
Source: Jon OggBank of America/Merrill Lynch is out with several keynote research calls on Tuesday. The firm is talking up the safe haven aspects of drug distributors like AmerisourceBergen Corp....
Source: Jon OggStocks have been in serious rally mode, to the point that the market has hit new all-time highs again. Now investors are trying to decide which stocks to buy, which stocks to sell, and...
Source: ThinkstockWhen short interest, or the amount of any specific stock sold short, starts to decline, that is usually a flashing sign for investors to take a look behind the curtain. In general,...
Source: ThinkstockThe analysts at Lazard Capital continue to believe that underlying fundamentals for the top companies in the drug channel (distributors, retailers, etc.) remain sound. Prescription...
Source: ThinkstockOne in every five jobs in the United States required a high level of knowledge in science, technology, engineering or math as of 2011. Since the industrial revolution, the share of...